Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After Progression on ICI-TKI Therapy | MicrobiomeTrials← Back to trialsNCT06563947
Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After Progression on ICI-TKI Therapy
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-09-03Est. Completion: 2027-05-20
Enrollment target: 30 participants Locations- Shenzhen Third People's Hospital, Shenzhen, China
Other microbiome trials you might be interested in
Hepatocellular CarcinomaLiver Cancer, AdultLiver NeoplasmMetastatic Liver Cancer
This is an open-label, multi-center, Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of ECT20…
Duarte, United StatesEst. completion Dec 31, 2027
Hepatocellular Carcinoma
The purpose of the study is to evaluate the efficacy of ZG005 combined with bevacizumab compared with sintilimab combine…
Nanjing, ChinaEst. completion Sep 2031